Caniceiro Ana B, Bueschbell Beatriz, Barreto Carlos A V, Preto António J, Moreira Irina S
CNC - Center for Neuroscience and Cell Biology, Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.
PhD in Biosciences, Department of Life Sciences, University of Coimbra, Calçada Martim de Freitas, 3000-456 Coimbra, Portugal.
Comput Struct Biotechnol J. 2022 Dec 21;21:586-600. doi: 10.1016/j.csbj.2022.12.031. eCollection 2023.
G protein-coupled receptors (GPCRs) mediate several signaling pathways through a general mechanism that involves their activation, upholding a chain of events that lead to the release of molecules responsible for cytoplasmic action and further regulation. These physiological functions can be severely altered by mutations in GPCR genes. GPCRs subfamily A17 (dopamine, serotonin, adrenergic and trace amine receptors) are directly related with neurodegenerative diseases, and as such it is crucial to explore known mutations on these systems and their impact in structure and function. A comprehensive and detailed computational framework - MUG (Mutations Understanding GPCRs) - was constructed, illustrating key reported mutations and their effect on receptors of the subfamily A17 of GPCRs. We explored the type of mutations occurring overall and in the different families of subfamily A17, as well their localization within the receptor and potential effects on receptor functionality. The mutated residues were further analyzed considering their pathogenicity. The results reveal a high diversity of mutations in the GPCR subfamily A17 structures, drawing attention to the considerable number of mutations in conserved residues and domains. Mutated residues were typically hydrophobic residues enriched at the ligand binding pocket and known activating microdomains, which may lead to disruption of receptor function. MUG as an interactive web application is available for the management and visualization of this dataset. We expect that this interactive database helps the exploration of GPCR mutations, their influence, and their familywise and receptor-specific effects, constituting the first step in elucidating their structures and molecules at the atomic level.
G蛋白偶联受体(GPCRs)通过一种通用机制介导多种信号通路,该机制涉及它们的激活,维持一系列导致负责细胞质作用和进一步调节的分子释放的事件。GPCR基因的突变可严重改变这些生理功能。GPCRs亚家族A17(多巴胺、5-羟色胺、肾上腺素能和痕量胺受体)与神经退行性疾病直接相关,因此,探索这些系统上已知的突变及其对结构和功能的影响至关重要。构建了一个全面而详细的计算框架——MUG(理解GPCRs的突变),阐述了关键的已报道突变及其对GPCRs亚家族A17受体的影响。我们探索了亚家族A17整体以及不同家族中发生的突变类型,以及它们在受体内的定位和对受体功能的潜在影响。进一步考虑突变残基的致病性对其进行分析。结果揭示了GPCR亚家族A17结构中突变的高度多样性,凸显了保守残基和结构域中相当数量的突变。突变残基通常是富集在配体结合口袋和已知激活微结构域的疏水残基,这可能导致受体功能的破坏。MUG作为一个交互式网络应用程序可用于管理和可视化此数据集。我们期望这个交互式数据库有助于探索GPCR突变、它们的影响以及它们家族性和受体特异性效应,这是在原子水平阐明其结构和分子的第一步。